SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
396Yeah, this last move is nothing but upper management dealing riches to itself. Iformer_pgs-2/2/2005
395I suppose it was more than a coincidence that first Stellar 3 was unblinded and Icebrg-2/2/2005
394The folks at CTIC appear pretty convinced that there is at least a "fair chIcebrg-2/2/2005
393What is the boards concensus on DNDN and their upcoming presentation in mid Febrtsq-2/1/2005
392<i>"You develop very intimate relationships with your patients</i&zeta1961-1/31/2005
391Medicare patients may get stuck with bill in fight over cancer drugs BY BOB LAMSam Citron-1/31/2005
390Thanks for providing the link to the study. Although the GOG study has generallygcrispin-1/29/2005
389<i>Don't you mean ovarian cancer?</i> Apparently so. Thanks veClarksterh-1/29/2005
38813) Maintenance pac (3 mo vs 12 mo) has shown benefit to Breast Cancer (21 vs 28gcrispin-1/29/2005
387Notes from Piper Jaffray. Caveats: a) These are notes from my perspective. ThClarksterh-1/29/2005
386Good list of oncology conferences here: docguide.com Anybody have a feel for whSam Citron-1/28/2005
385CTIC Investors Calendar of Upcoming Events and Potential Catalysts Feb. 23-24 BSam Citron-1/28/2005
384For comparison . . . ctclconsult.com >>Sequential Combination Chemothtuck-1/27/2005
383XYOTAX(TM) Pivotal Trial in Non-Small Cell Lung Cancer, STELLAR 3, Reaches RequiIan@SI-1/27/2005
382LEAPs now trading pacificex.comSam Citron-1/26/2005
381Sounds consistent with what they said last August. A new report was issued todaIan@SI-1/21/2005
380Erik, I have Briefing "lite" (via Schwab) and I can't find that ittom pope-1/21/2005
379Thanks Erik, story sounds vaguely similar to APPX history. What is with these tExtra Pale-1/21/2005
378"well-entrenched bias against the co by investors" There are a numberIcebrg-1/21/2005
377Erik, what is the reason for their statement "well-entrenched bias against Extra Pale-1/21/2005
376[Supposed to be] From Briefing.com. [I have not been able to verify the source, Icebrg-1/21/2005
375The Wall Street Journal, Harvard Business Review, Warren Buffet... all think thaDoc Bones-1/13/2005
374The stock here is not that eggregious - $3 MM versus his annual cash comp of aboRobohogs-1/12/2005
373American Bioscience Gains FDA Approval For Abraxane By Karen Pihl-Carey Staff Icebrg-1/11/2005
372<Zeta reply> Message 20930125 I'd written one in a different tone...zeta1961-1/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News